CUC Inc. (TYO:9158)
Japan · Delayed Price · Currency is JPY 670.00
-13.00 (-1.90%)
Nov 5, 2026, 3:30 PM JST
CUC Inc. Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 56,797 | 54,353 | 47,043 | 33,025 | 35,210 | 35,314 |
Revenue Growth | 9.81% | 15.54% | 42.45% | -6.21% | -0.29% | 112.66% |
Gross Profit Gross Profit Growth | 26,141 | 25,413 | 23,172 | 15,923 | 13,776 | 14,246 |
Operating Income Operating Income Growth | 5,019 | 4,347 | 5,107 | 3,738 | 3,683 | 3,678 |
Net Income Net Income Growth | 2,141 | 2,854 | 3,131 | 2,595 | 2,423 | 2,707 |
Earnings Per Share EPS Growth | 73.03 | 97.35 | 106.80 | 93.98 | 113.90 | 129.68 |
EPS Growth | 23.46% | -8.85% | 13.65% | -17.49% | -12.17% | 146.04% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 |
Hospice Hospice Growth | 17,422 | 16,714 | 13,759 | 10,389 |
In-Home Nursing In-Home Nursing Growth | 13,164 | 12,949 | 12,309 | 10,946 |
Medical Institution Medical Institution Growth | 18,631 | 17,312 | 17,603 | 12,182 |
Unllocated Adjustment Unllocated Adjustment Growth | -563 | -475 | -314 | -696 |
Others Others Growth | 177 | 148 | 120 | 205 |
Medical Care Residence Medical Care Residence Growth | 7,966 | 7,704 | 3,567 | - |
Total Total Growth | 56,797 | 54,352 | 47,044 | 33,026 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 16,120 | 15,835 | 7,533 | 8,256 | 4,120 | 4,355 |
Total Debt Total Debt Growth | 55,502 | 52,533 | 43,544 | 26,719 | 21,452 | 14,901 |
Net Cash (Debt) Net Cash Growth | -39,382 | -36,698 | -36,011 | -18,463 | -17,332 | -10,546 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1343.39 | -1251.84 | -1228.40 | -668.63 | -814.74 | -505.31 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 5,706 | 2,503 | 4,156 | - | - |
Capital Expenditures CapEx Growth | - | -6,618 | -5,547 | -4,859 | - | - |
Free Cash Flow Free Cash Flow Growth | - | -912 | -3,044 | -703 | - | - |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 46.02% | 46.76% | 49.26% | 48.22% | 39.13% | 40.34% |
Operating Margin | 8.84% | 8.00% | 10.86% | 11.32% | 10.46% | 10.42% |
Pretax Margin | 7.32% | 9.40% | 11.15% | 12.53% | 10.32% | 10.26% |
Profit Margin | 3.77% | 5.25% | 6.66% | 7.86% | 6.88% | 7.67% |
FCF Margin | - | -1.68% | -6.47% | -2.13% | - | - |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 9.17 | 8.95 | 12.85 | 30.54 | - | - |
Forward PE | 14.28 | 9.26 | 11.35 | 30.11 | - | - |
PS Ratio | 0.36 | 0.47 | 0.86 | 2.40 | - | - |